Gene: DERA
Official Full Name: deoxyribose-phosphate aldolaseprovided by HGNC
Gene Summary: Enables deoxyribose-phosphate aldolase activity. Involved in deoxyribonucleoside catabolic process. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO23111 | DERA Knockout cell line (HeLa) | Human | DERA | 1:3~1:6 | Negative | Online Inquiry |
KO23112 | DERA Knockout cell line (HCT 116) | Human | DERA | 1:2~1:4 | Negative | Online Inquiry |
KO23113 | DERA Knockout cell line (HEK293) | Human | DERA | 1:3~1:6 | Negative | Online Inquiry |
KO23114 | DERA Knockout cell line (A549) | Human | DERA | 1:3~1:4 | Negative | Online Inquiry |
DERA Gene Knockout Cell Lines are specialized cell lines engineered to lacking specific genes, allowing researchers to explore the functional roles of target genes in various biological processes. Utilizing advanced CRISPR-Cas9 technology, these knockout cell lines provide a robust platform for dissecting gene function, elucidating disease mechanisms, and validating therapeutic targets. The gene knockout process involves precise modifications to the genomic DNA, resulting in the complete loss of function of the selected gene, thereby facilitating direct observation of the phenotypic consequences of gene disruption.
The scientific importance of DERA Gene Knockout Cell Lines lies in their versatility as a tool for fundamental research and clinical applications. They enable researchers to investigate gene expression regulation, cellular signaling pathways, and metabolic functions. In addition, these cell lines are crucial for drug discovery and development, allowing for the identification of potential drug targets and the evaluation of pharmacological agents in a controlled environment. Their use in modeling human diseases, such as cancer, neurodegenerative disorders, and genetic conditions, significantly contributes to advancing personalized medicine.
One of the key advantages of DERA Gene Knockout Cell Lines is the precision and efficiency achieved through CRISPR technology, compared to traditional knockout methods such as homologous recombination. This results in a quicker turnaround time for generating knockout lines, lower off-target effects, and improved reproducibility. Furthermore, our product offerings are accompanied by extensive documentation and support resources, ensuring ease of integration into existing research protocols.
For researchers, clinicians, and pharmaceutical companies, DERA Gene Knockout Cell Lines are invaluable assets that not only accelerate discovery timelines but also enhance the fidelity of experimental outcomes. With our commitment to innovation and quality, our company stands as a trusted leader in the field of biological products, dedicated to providing advanced solutions that empower scientific inquiry and clinical breakthroughs.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.